Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
10.82
-0.14 (-1.28%)
Sep 30, 2025, 5:31 PM CET

Newron Pharmaceuticals Revenue

Newron Pharmaceuticals had revenue of 11.90M EUR in the half year ending June 30, 2025, with 116.56% growth. This brings the company's revenue in the last twelve months to 59.88M, up 759.12% year-over-year. In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M with 467.41% growth.

Revenue (ttm)
59.88M EUR
Revenue Growth
+759.12%
P/S Ratio
3.86
Revenue / Employee
2.72M EUR
Employees
22
Market Cap
215.98M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202451.39M42.33M467.41%
Dec 31, 20239.06M2.96M48.62%
Dec 31, 20226.09M332.00K5.76%
Dec 31, 20215.76M504.00K9.59%
Dec 31, 20205.26M-1.78M-25.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition